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Abstract. 
 
Human cells express two kinases that are re-
lated to the yeast mitotic checkpoint kinase BUB1. 
hBUB1 and hBUBR1 bind to kinetochores where they 
are postulated to be components of the mitotic check-
point that monitors kinetochore activities to determine 
if chromosomes have achieved alignment at the spindle 
equator (Jablonski, S.A., G.K.T. Chan, C.A. Cooke,
 
W.C. Earnshaw, and T.J. Yen. 1998. 
 
Chromosoma
 
. 107:
386–396). In support of this, hBUB1 and the homolo-
gous mouse BUB1 have been shown to be important 
for the mitotic checkpoint (Cahill, D.P., C. Lengauer, J. 
Yu, G.J. Riggins, J.K. Willson, S.D. Markowitz, K.W. 
Kinzler, and B. Vogelstein. 1998. 
 
Nature
 
. 392:300–303; 
Taylor, S.S., and F. McKeon. 1997. 
 
Cell
 
. 89:727–735). We 
now demonstrate that hBUBR1 is also an essential 
component of the mitotic checkpoint. hBUBR1 is re-
quired by cells that are exposed to microtubule inhibi-
tors to arrest in mitosis. Additionally, hBUBR1 is essen-
tial for normal mitotic progression as it prevents cells 
from prematurely entering anaphase. We establish that 
one of hBUBR1’s checkpoint functions is to monitor 
kinetochore activities that depend on the kinetochore 
motor CENP-E. hBUBR1 is expressed throughout the 
cell cycle, but its kinase activity is detected after cells 
have entered mitosis. hBUBR1 kinase activity was rap-
idly stimulated when the spindle was disrupted in mi-
totic cells. Finally, hBUBR1 was associated with the cy-
closome/anaphase-promoting complex (APC) in 
mitotically arrested cells but not in interphase cells. The 
combined data indicate that hBUBR1 can potentially 
provide two checkpoint functions by monitoring 
CENP-E–dependent activities at the kinetochore and 
regulating cyclosome/APC activity.
Key words: kinetochore • hBUBR1 • mitotic check-
point •anaphase-promoting complex • CENP-E
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 chromosome segregation relies on the in-
teractions between the kinetochore and microtu-
bules of the spindle. The process by which kineto-
chores capture a microtubule is stochastic in nature, a
chance encounter, which is prone to error (Nicklas, 1997).
Thus, it is critical that cells are able to delay exit from mi-
tosis until all chromosomes have aligned at the spindle
equator. The mitotic checkpoint is able to determine
whether chromosomes have aligned by monitoring the ki-
netochore, a structure that mediates attachment of the
chromosome to microtubules and is directly responsible
for chromosome motility (Inoue and Salmon, 1995; Yen
and Schaar, 1996; Rieder and Salmon, 1998). The check-
point is sensitive to the presence of even a single unat-
tached kinetochore, as this is sufficient to delay cells from
exiting mitosis (Rieder et al., 1995). The precise biochemi-
cal mechanism by which an unattached kinetochore blocks
 
entry into anaphase remains undefined, but it appears
to be sensitive to kinetochore microtubule attachments
(Rieder et al., 1994) and to the level of tension that is ex-
erted on the kinetochore (Li and Nicklas, 1995).
Molecular insights into the mitotic checkpoint have
come from the identification of seven genes in budding
yeast that are essential for the mitotic checkpoint. In the
presence of spindle or kinetochore defects, the MPS1 ki-
nase (Weiss and Winey, 1996) and the BUB1/BUB3 ki-
 
nase complex (Hoyt et al., 1991; Roberts et al., 1994), along
with MAD1, MAD2, MAD3, and BUB2, are required to
block cells in mitosis (Li and Murray, 1991; Hardwick and
Murray, 1995). The mitotic checkpoint appears to be
highly conserved throughout evolution, as homologues of
many of the yeast checkpoint proteins have also been
 
identified in 
 
Drosophila
 
 and vertebrates. Analysis of
MAD1 (Chen et al., 1998; Jin et al., 1998), MAD2 (Chen
et al., 1996; Li and Benezra, 1996), BUB1, BUBR1, and
BUB3 (Taylor and McKeon, 1997; Basu et al., 1998; Cahill
et al., 1998; Chan et al., 1998; Jablonski et al., 1998; Taylor
et al., 1998) in higher eukaryotes show that these proteins
accumulate at kinetochores where they are postulated to
monitor kinetochore functions and participate in generat-
ing the wait anaphase signal. Consistent with this possibil-
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ity, unattached kinetochores exhibited a higher level of
some of these checkpoint proteins than kinetochores that
were aligned at the spindle equator. Functional studies
have shown that MAD1 and MAD2 are essential compo-
nents of the mitotic checkpoint in vertebrate cells and in
cycling 
 
Xenopus
 
 egg extracts (Chen et al., 1996; Li and
Benezra, 1996; Waters et al., 1998). Similarly, mouse
BUB1 (mBUB1) has also been shown to be essential for
the mitotic checkpoint (Taylor and McKeon, 1997).
The target of the mitotic checkpoint in both yeast and
vertebrates is the cyclosome/anaphase-promoting complex
(APC),
 
1
 
 a multisubunit E3 ubiquitin-ligase that specifies
the proteolytic destruction of specific proteins to initiate
the onset of anaphase (Sudakin et al., 1995; King et al.,
1996; Hershko and Ciechanover, 1998). MAD2 was found
to interact with the cyclosome/APC in mitotically arrested
cells and inhibit its ubiquitination activity in vitro and in
vivo (Li et al., 1997; Chen et al., 1998; Fang et al., 1998;
Gorbsky et al., 1998). Genetic and biochemical studies
have shown that the association between MAD2 and the
cyclosome/APC is mediated by p55CDC/cdc20 (Fang et al.,
1998; Hwang et al., 1998; Kallio et al., 1998; Kim et al.,
1998), an evolutionarily conserved protein that is essential
for the metaphase–anaphase transition (Dawson et al.,
1995; Visintin et al., 1997; Kallio, 1998). The mechanism
by which unaligned chromosomes specify the inhibition of
the cyclosome/APC by MAD2 is unclear, but a tentative
model suggests that unattached kinetochores serve to con-
vert MAD2 into an inhibitor of the cyclosome/APC (Chen
et al., 1998; Gorbsky et al., 1998). This possibility is partly
supported by the finding that recombinant human MAD2
can form a homotetramer and this complex is more effi-
cient at inhibiting the cyclosome/APC than monomeric
forms of MAD2 (Fang et al., 1998).
In spite of the significant advances in our understanding
of MAD2 function, the picture remains incomplete due to
the lack of understanding of the functions of the other
checkpoint proteins. The situation in mammalian cells
may be even more complex than in budding yeast as the
function and structure of mammalian kinetochores is
vastly more complicated and may require a more elabo-
rate checkpoint monitoring system. This possibility is con-
sistent with the recent finding that mammalian cells ex-
press two BUB1-related kinases that appear to have
evolved from a common ancestral BUB1 kinase. hBUB1
(the homologue of mBUB1) and hBUBR1 are human
BUB1-related kinases that were found to be mutated in 2
out of 20 colorectal carcinomas that exhibited a chromo-
some instability phenotype (Cahill et al., 1998). The muta-
tions identified in hBUB1 were confirmed to interfere
with the mitotic checkpoint as the mutant protein dis-
rupted the activity of the wild-type hBUB1 in a dominant
negative fashion (Cahill et al., 1998). Although colorectal
carcinomas that were heterozygous for hBUBR1 muta-
tions were also identified in the study (Cahill et al., 1998),
the role of hBUBR1 in the mitotic checkpoint was not
tested.
 
hBUBR1 was also independently isolated based on its
similarities with a portion of the yeast checkpoint protein
MAD3 (Taylor et al., 1998). The significance of this simi-
larity is unknown but it is noteworthy that other members
of the BUB1 kinase family also share the same MAD3 ho-
mology domain (Roberts et al., 1994; Taylor and McKeon,
1997; Chan et al., 1998). Clues to hBUBR1 function came
when it was found to associate with the kinetochore motor
CENP-E (Chan et al., 1998). Although this interaction was
initially identified in a yeast two-hybrid screen for proteins
that associate with CENP-E, a stable complex of hBUBR1
and CENP-E was detected in Hela cells. CENP-E is a ki-
netochore-associated kinesin motor protein whose func-
tion is in microtubule attachment to kinetochores and in
the alignment of chromosomes to the metaphase plate
(Schaar et al., 1997; Wood et al., 1997). The function of
CENP-E is likely to be monitored by the mitotic check-
point as cells invariably were arrested in mitosis when
their kinetochores lacked CENP-E functions (Schaar et
al., 1997). Taken together, we postulated that the CENP-
E–hBUBR1 complex might be integral parts of a mecha-
nosensor that link kinetochore motility with checkpoint
control (Chan et al., 1998).
In this paper, we establish the importance of the
hBUBR1 kinase in the mitotic checkpoint and provide
mechanistic insights into its checkpoint functions. We
show that one function of hBUBR1 is to monitor kineto-
chore activities that require CENP-E. We also demon-
strate that hBUBR1 is a mitotic-specific kinase that associ-
ates with a large fraction of the cyclosome/APC during
mitosis. We propose a working model that integrates these
two activities to account for how local defects at the ki-
netochore are detected, relayed, and amplified to a global
level to block premature entry into anaphase. The similar-
ities shared between hBUBR1 and the MAD2–p55CDC
complex suggests that they can function as an integrated
complex or act along parallel pathways in the mitotic
checkpoint.
 
Materials and Methods
 
Cell Culture
 
Hela cells were grown in DME supplemented with 10% FBS. Hela cells
adapted for growth in suspension were cultured in SME supplemented
with 10% FBS and 1% pluronic acid. K562 suspension cultures were
grown in RPMI 1640 supplemented with 10% FBS. All cells were grown
in a humidified 37
 
8
 
C chamber at 5% CO
 
2
 
. Centrifugal elutriation was per-
formed using a Beckman centrifuge (J6-MC) with the JE5.0 rotor as de-
scribed (Gately et al., 1998). Samples were taken from each fraction and
analyzed for cell cycle distribution by FACS. Hela cells arrested in mitosis
were obtained by growing them in the presence of nocodazole (0.06 
 
m
 
g/
ml) for 12–16 h. Both normal and nocodazole-blocked mitotic cells were
harvested from the culture dishes by mechanical shakeoff.
 
Construction and Expression of Mutant hBUBR1
 
Full-length gfp-hBUBR1 expression construct was described previously
(Chan et al., 1998). The mutant gfp:hBUBR1
 
D
 
kinase construct was made
by deleting nine amino acids (amino acids 795–803, KVSSQPVPW) from
the most conserved kinase subdomain II (Hunter, 1987; Hanks and
Quinn, 1991). Deletion was accomplished by PCR-based mutagenesis.
Transient transfections were performed by lipofection using LT2 (Pan-
Vera) as described (Chan et al., 1998).
 
Microinjection
 
Hela cells were plated onto gridded coverslips and were synchronized at
 
1. 
 
Abbreviations used in this paper: 
 
ACA, anticentromere autoimmune
antibodies; APC, anaphase-promoting complex; CENP-E, centromere
protein E; DAPI, 4
 
9
 
,6-diamidino-2-phenylindole. 
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the G1/S boundary by a double thymidine block. Before injection, the me-
dia was replaced with fresh Hepes buffered DME plus 10% FBS. Cells
were injected 1–2 h after they were released from the G1/S boundary. Mi-
croinjection was performed with a semi-automatic injector (model 5412;
Eppendorf Scientific, Inc.) and the Eppendorf automated micromanipula-
tor (model 5402). For each coverslip, 200–300 cells were injected with
each antibody mix over a course of 
 
z
 
30 min. Multiple coverslips were in-
jected to accommodate time course experiments where samples had to be
taken at different times. The affinity-purified hBUBR1 and CENP-E anti-
bodies used for the injection experiments have been previously described
(Schaar et al., 1997; Chan et al., 1998). Nonimmune IgG was isolated from
sera, which was originally used to affinity purify hBUBR1 antibodies, and
verified by immunofluorescence and Western blots to no longer contain
detectable levels of hBUBR1 antibodies. Antibodies were kept in Ca
 
11
 
-
and Mg
 
11
 
-free PBS and were filtered through a 0.22-
 
m
 
m Millipore micro-
filtration cup before use. To visualize the cells that had been injected with
antibodies, cells were fixed for 7 min in 3.5% paraformaldehyde in PBS
and permeabilized in 0.2% Triton X-100 for 3–5 min before proceeding
with antibody incubations. To minimize loss of loosely attached mitotic or
apoptotic cells, the coverslips were centrifuged at 200 
 
g
 
 for 3 min in a clin-
ical centrifuge (GPKR; Beckman). For time-lapse microscopy, Hela cells
were plated onto 35-mm glass bottom microwell dishes (MatTek Corp.),
and cells were monitored with a 60
 
3
 
 PlanApo objective mounted on a Ni-
kon Eclipse TE300 inverted microscope. Cells were kept at 37
 
8
 
C with a
35-mm tissue culture dish stage warmer regulated by a temperature con-
troller (TC-102; Medical Systems Corp.). Time-lapse images were cap-
tured using a Sensys CCD camera (Photometric) that was controlled by
Image-Pro Plus software (Phase 3 Imaging Systems).
 
Immunofluorescence Microscopy
 
Cells on coverslips were fixed, permeabilized, and stained as described
(Chan et al., 1998). Injected rabbit antibodies were detected with Cy5-
conjugated anti-rabbit secondary antibody (Jackson ImmunoResearch
Laboratories). Endogenous hBUBR1 was visualized with a rat anti–
hBUBR1 antibody that was generated and affinity-purified the same way
as the previously described rabbit hBUBR1 antibodies (Chan et al., 1998;
Jablonski et al., 1998). Anticentromere autoimmune serum was a gift of K.
Sullivan (Scripps Research Institute, La Jolla, CA). Microtubules were
stained with anti–
 
a
 
-tubulin monoclonal antibody (Sigma Chemical Co.).
The primary antibodies were visualized using an appropriate secondary
antibody that was coupled to Cy2 or Texas red (Jackson Immuno-
Research Laboratories). DNA was stained with 0.1 
 
m
 
g/ml of 4
 
9
 
,6-diam-
idino-2-phenylindole (DAPI). Stained cells were examined with either a
40 or 100
 
3
 
 PlanNeofluor objective mounted on a Nikon Microphot SA
that was equipped with epifluorescence optics. Images were captured with
a TEC-1 CCD camera (Dage-MTI) that was controlled with IP LabSpec-
trum v2.0.1 (Scanalytics Inc.) and contrast enhanced with Adobe Photo-
shop 5.0 (Adobe Systems Inc.).
 
Immunoprecipitation and Western Blots
 
Cells were harvested, washed, and lysed in NP-40 lysis buffer (1% NP-40,
50 mM Tris-Cl, pH 7.5, 150 mM NaCl, 1 mM DTT) supplemented with
protease and phosphatase inhibitors as described previously (Gately et al.,
1998). Cell lysates were centrifuged at 10,000 
 
g
 
 at 4
 
8
 
C for 15 min. The pro-
tein concentrations of the lysates were determined (BCA protein assay;
Pierce Chemical Co.) and adjusted to the same protein concentration. Im-
munoprecipitation was performed with 300 or 500 
 
m
 
g of lysate and the fi-
nal concentration of hBUBR1 antibody was 
 
z
 
2 
 
m
 
g/ml. For FPLC separa-
tion, S100 was loaded onto a Superose 6 column (Amersham Pharmacia
Biotech Inc.), and proteins were eluted in NP-40 lysis buffer with protease
and phosphatase inhibitors. Fractions containing cyclosome/APC were
combined, concentrated with a Centricon 100 (Amicon Inc.), and incu-
bated with hBUBR1 antibodies. To solubilize hBUBR1 that is associated
with the kinetochore, chromosomes were boiled in 2% SDS for 2 min, di-
luted 10-fold with NP-40 lysis buffer, clarified, and processed for immuno-
precipitation. Antibody was incubated with lysates for 3 h at 4
 
8
 
C, and
then 30 
 
m
 
l of 50% slurry of protein A–Sepharose (Repligen) was added
and incubation proceeded for another 30 min. The beads were recovered
by low speed centrifugation, washed five times in 0.5 ml of ice-cold lysis
buffer before SDS gel sample buffer was added. In some cases, hBUBR1
immunoprecipitates were incubated with 400 units of 
 
l
 
 protein phos-
phatase (New England Biolabs Inc.) for 30 min at 30
 
8
 
C in buffer supplied
by the manufacturer. Samples from the immunoprecipitates or whole cell
lysates were separated through 4–12% gradient SDS-PAGE, transferred
onto Immobilon
 
 
 
P
 
 
 
(Millipore), and then processed for Western blots.
Antibodies to cyclosome/APC subunits hscdc16 and hscdc27 were gifts
of Dr. P. Hieter (University of British Columbia, Vancouver, British Co-
 
lumbia, Canada). APC7 antibodies were a gift from Dr. J.M. Peters (IMP,
Vienna, Austria). Rabbit hBUB3 antibodies were generated against GST:
hBUB3 fusion protein and affinity-purified as described (Chan et al.,
1998). Primary antibodies were detected with alkaline phosphatase–conju-
gated anti-rabbit secondary antibodies used at 1:30,000 (Sigma Chemical
Co.), and then processed for CDP-Star chemiluminescence detection
(Tropix).
 
Kinase Assays
 
hBUBR1 was immunoprecipitated from lysates containing identical
amounts of protein as described above. After washing the pelleted beads
five times in NP-40 lysis buffer, the beads were washed three times in ki-
nase buffer (50 mM Tris-Cl, pH 7.4, 10 mM MgCl
 
2
 
, 10 mM 
 
b
 
 glycerophos-
phate). Beads were incubated in kinase buffer that contained 50 
 
m
 
M ATP
and 20 
 
m
 
Ci 
 
g
 
-[
 
32
 
P]ATP at 25
 
8
 
C for 15 min. Cold ATP was added to a final
concentration of 0.5 mM and the reaction was allowed to proceed for an-
other 15 min before SDS sample buffer was added. The immunoprecipita-
tion–kinase samples were boiled and separated through a 4–15% gradient
gel, fixed, dried, and then subjected to autoradiography. Quantitation was
done using a Bio-Imaging analyzer (Fujix BAS1000; Fuji PhotoFilm Co.,
Ltd.).
 
Results
 
hBUBR1 Is Required for the Mitotic Checkpoint
 
Two complementary approaches were used to examine if
hBUBR1 function is required for the mitotic checkpoint in
Hela cells. Our first strategy to inhibit hBUBR1 activity
was to microinject hBUBR1 antibodies into cells and test
the response of the injected cells to the microtubule inhib-
itor nocodazole. The hBUBR1 antibodies used for the in-
jection experiments have been shown not to cross-react
with hBUB1 as determined by Western blots and immu-
noprecipitations (Chan et al., 1998; Jablonski et al., 1998).
Hela cells synchronized at the G1/S boundary were micro-
injected with hBUBR1 or nonimmune antibodies shortly
after they were released from the G1/S boundary. Approx-
imately 2 h before the synchronized cells were expected to
enter mitosis, nocodazole was added to the medium and
the injected cells were sampled at various times during the
ensuing 8 h (Fig. 1, A and B). Mitotic cells were scored by
the presence of condensed chromosomes which aggre-
gated near the center of the cell when the spindle is abol-
ished by nocodazole (Fig. 1 A, rows 1 and 2, left). Approx-
imately 12 h after release from the G1/S boundary, most
cells have entered mitosis. At this time, there was no sig-
nificant difference between the mitotic indices of the cells
that were injected with hBUBR1 or the nonimmune anti-
bodies. Thus, injection of antibodies did not interfere with
mitotic entry. Nonimmune antibodies were diffusely dis-
tributed throughout the mitotic cell (Fig. 1 A, row 1, mid-
dle) and did not interfere with the localization of hBUBR1
at kinetochores of the unaligned chromosomes (Fig. 1 A,
row 1, right). In contrast, the injected hBUBR1 antibodies
were concentrated at the kinetochores of the unaligned
chromosomes (Fig. 1 A, row 2, middle). The presence of
hBUBR1 at kinetochores of these cells was independently
confirmed by staining with hBUBR1 antibodies (Fig. 1 A,
row 2, right).
When cells were examined at later times after nocoda-
zole treatment, the mitotic index of cells injected with non-
immune IgG remained high, whereas the mitotic index of
cells injected with hBUBR1 antibodies was about three-
fold lower (Fig. 1 B). The decrease in the mitotic index of 
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cells that were injected with the hBUBR1 antibodies was
accompanied by a fivefold rise in the number of interphase
cells with aberrantly shaped nuclei relative to the negative
control (Fig. 1 A, row 3, and B). The flattened morphology
as well as the presence of nuclei indicated that these cells
exited mitosis (Fig. 1 A, row 3). The presence of paired
centromeres, as revealed by staining with an anticen-
tromere autoimmune (ACA) serum, suggested that either
the chromosomes did not separate or had separated but
re-replicated (Fig. 1 A, row 3, right, inset).
To directly confirm that inhibition of hBUBR1 abro-
gated the mitotic checkpoint and caused cells to exit mito-
sis, time-lapse videomicroscopy was used to follow the fate
of nocodazole-treated cells that were microinjected with
hBUBR1 antibodies. Fig. 1 C shows that within 30 min af-
ter the cell entered mitosis, the cell began to flatten out. 2 h
later, the presence of a nucleus demonstrated that it had
clearly exited mitosis (Fig. 1 C, 150’). At this level of reso-
lution, we could not determine how rapidly cells injected
with hBUBR1 antibodies exited mitosis. Uninjected cells
on the same coverslip as well as cells injected with nonim-
mune antibodies remained blocked in mitosis for up to 16 h
(data not shown).
To obtain independent verification of the microin-
jection results, we attempted to disrupt endogenous
hBUBR1 function by targeting an hBUBR1 mutant to ki-
netochores. We created a mutant by deleting nine amino
acids (residues 795–803) from subdomain II of the con-
served catalytic core of the hBUBR1 kinase. Western
blots confirmed that both mutant and wild-type hBUBR1
were expressed at equivalent levels (data not shown).
Both mutant and wild-type gfp:hBUBR1 were transfected
into synchronized Hela cells shortly after they were re-
leased from the G1/S boundary (Fig. 2). Nocodazole was
added 
 
z
 
2 h before the cells were expected to enter mito-
sis. By 12 h after release from the G1/S boundary, mitotic
cells expressing both mutant and wild-type gfp-hBUBR1
at their kinetochores were identified (Fig. 2 A, rows 1 and
2). After overnight incubation in the presence of nocoda-
zole, the mitotic index of cells expressing the mutant gfp:
hBUBR1 was 
 
z
 
2 times lower than for wild-type gfp:
hBUBR1–transfected cells (Fig. 2 B). In concordance
with the microinjection results, many of the cells express-
ing the mutant hBUBR1 exited mitosis and formed aber-
rant shaped nuclei (Fig. 2 A, row 3, and B). The accumu-
lation of the gfp:hBUBR1
 
D
 
kinase in the cytoplasm of
these aberrant interphase cells is consistent with the dis-
tribution of endogenous hBUBR1 in interphase cells as
previously reported (Chan et al., 1998). The microin-
jection and transfection experiments demonstrate that
hBUBR1 kinase is likely to be an essential component of
the mitotic checkpoint.
 
hBUBR1 Is Essential for a Normal Mitosis
 
We have previously shown that hBUBR1 can form a com-
plex with the kinetochore motor CENP-E (Chan et al.,
1998). If hBUBR1 can monitor kinetochore microtubule
interactions mediated by CENP-E as part of its normal
checkpoint function, disruption of hBUBR1 might cause
cells to exit mitosis prematurely. Alternatively, hBUBR1
might regulate CENP-E functions that are important for
 
chromosome alignment. In this case, loss of hBUBR1
should interfere with CENP-E functions at the kineto-
chore and block cells in mitosis with unaligned chromo-
somes (Schaar et al., 1997). To test the importance of
hBUBR1 during normal mitosis, the fates of synchronized
cells that were either injected with hBUBR1 antibodies or
transfected with the gfp:hBUBR1
 
D
 
kinase were deter-
mined. Approximately 12 h after release from the G1/S
boundary, cells that were injected with nonimmune IgG
were found in prometaphase and metaphase with the ma-
jority being at metaphase (Fig. 3 A, row 1). Immunofluo-
rescence staining revealed that the metaphase cells exhib-
ited detectable levels of hBUBR1 at their kinetochores
despite the presence of nonimmune antibodies through-
out the cell (Fig. 3 A, row 1, middle and right). For cells
injected with the hBUBR1 antibody, most of the mitotic
cells were in prometaphase. The injected hBUBR1 anti-
bodies were found throughout the cell including kinet-
ochores (Fig. 3 A, row 2, middle). The presence of
hBUBR1 antibodies at the kinetochores did not interfere
with CENP-E localization (Fig. 3 A, row 2, right). Al-
though a few metaphase cells injected with hBUBR1
were seen, we consistently identified anaphase cells that
contained lagging chromosomes (Fig. 3 A, row 3, left).
These cells appeared to be in late anaphase as they con-
tained a mature cleavage furrow that was concentrated
with CENP-E (Fig. 3 A, row 3, right). The presence of
lagging chromosomes suggested that these cells exited mi-
tosis in the presence of unaligned chromosomes and gave
rise to the high frequency of aberrantly divided cells that
accumulated at later time points (Fig. 3 A, row 4, and B).
The nuclei of the cells injected with hBUBR1 antibodies
were abnormally shaped and DNA was invariably found
in between the two divided cells (Fig. 3 A, row 4, left).
The DNA in between the cells was derived from chromo-
somes because they contained centromeres as determined
by ACA staining (Fig. 3 A, row 5, right, inset). However,
we cannot distinguish whether the foci of ACA stain-
ing represent separated centromeres or fragmented cen-
tromeres. This cut phenotype was specific for hBUBR1
antibodies as this was not observed in uninjected cells
or cells injected with nonimmune antibodies. In fact,
hBUBR1 antibody injection did not produce any normal
telophase cells (Fig. 3 B).
Similar results were obtained when synchronized Hela
cells were transfected with the mutant hBUBR1
 
D
 
kinase.
In transfected cells that had progressed into mitosis, the
mutant hBUBR1 was concentrated at kinetochores (Fig. 3
C, top right). At later times, there was a large increase in
aberrantly divided cells with the cut phenotype (Fig. 3 C,
bottom left). Both mock and wild-type gfp:hBUBR1–
transfected cells divided normally and did not exhibit the
cut phenotype (data not shown). The combined data sug-
gest that disruption of hBUBR1 function caused the cells
to exit mitosis in the presence of unaligned chromosomes.
 
hBUBR1 Monitors CENP-E Kinetochore Functions
 
We have previously shown that disruption of CENP-E
functions at kinetochores prevented chromosome alignment
and arrested cells in mitosis for 
 
.
 
12 h (Schaar et al., 1997).
To test whether hBUBR1 is required for this checkpoint, 
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we coinjected hBUBR1 and CENP-E antibodies into syn-
chronized Hela cells, and then compared the fates of these
cells to those that were injected with CENP-E antibodies
alone. Injection of CENP-E antibodies blocked the assem-
bly of CENP-E onto kinetochores (Fig. 1 A, left and mid-
dle) but did not interfere with kinetochore localization of
hBUBR1 (Fig. 4 A, left gallery, row 1) or the distribution
of other centromere components that were recognized by
ACA (Fig. 4 A, left gallery, row 2). As shown previously,
the mitotic block induced by injection of CENP-E anti-
bodies is the direct result of disruption of kinetochore
function and not bipolar spindle formation (Fig. 4 A, left
gallery, row 3).
Cells coinjected with CENP-E and hBUBR1 antibodies
Figure 1. hBUBR1 is essential for cells to arrest in mitosis in the presence of nocodazole. (A) Immunofluorescence staining of Hela
cells injected with antibodies and exposed to nocodazole. (row 1 and 2) 12 h after release from the G1/S boundary, nonimmune– and
hBUBR1 antibody–injected cells have entered mitosis in the presence of nocodazole with unaligned chromosomes (left). Injected anti-
bodies were visualized with Cy5 anti-rabbit secondary antibodies (middle) and endogenous hBUBR1 was visualized with a rat anti–
hBUBR1 antibody and Cy2 anti-rat secondary antibodies (right). (row 3) Cells injected with hBUBR1 (middle) exited mitosis in the
presence of nocodazole and formed aberrantly shaped nuclei (left) that contained paired centromeres as determined by ACA and Cy2
anti-human secondary antibody staining (right, arrowheads in the inset). Chromosomes and nuclei were visualized by DAPI staining
(left). Images in rows 1 and 2 were captured with a 1003 objective, whereas row 3 was visualized with a 403 objective. (B) Histogram
comparing the fates of Hela cells injected with nonimmune or hBUBR1 antibodies after exposure to nocodazole. Synchronized Hela
cells were injected within 2 h after their release from the G1/S boundary, nocodazole was added 8 h after release from the G1/S bound-
ary and sampled 4, 6, and 8 h later. Hela cells normally enter mitosis between 10–12 h after release from the G1/S boundary. The histo-
gram compares the mitotic (open bars), multi-nucleated (striped bars), and apoptotic (dotted bars) indices of cells injected with
hBUBR1 and nonimmune antibodies at 16 h after release from the G1/S boundary. Approximately 80–120 injected cells were counted
for each experiment. The plotted values are the means plus SD from at least three experiments. (C) A single cell microinjected with
hBUBR1 antibodies and incubated in the presence of nocodazole was followed by time-lapse videomicroscopy shortly after it entered
mitosis (time 0). Frames were selected from a 4.5-h long time-lapse experiment. Actual time in minutes is labeled in the bottom right
corners of each frame. Bars, 10 mm. 
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entered mitosis. Immunofluorescence staining confirmed
that hBUBR1 remained at kinetochores (Fig. 4 A, right
gallery, row 1, right) of the injected cells. 16 h after release
from the G1/S boundary, we counted cells that were either
in mitosis, telophase, aberrantly divided cut, or apoptosis.
Cells injected with just CENP-E antibodies were arrested
in mitosis with unaligned chromosomes (Fig. 4 B). No cells
were found to be apoptotic, in telophase, or cut. Examina-
 
tion of the cells that were coinjected with hBUBR1 and
CENP-E antibodies showed an 
 
z
 
5-fold reduction in the
number of mitotic cells relative to cells injected with
CENP-E alone (Fig. 4 B). The reduction of mitotic cells
was accompanied by a large increase in the number of ab-
errantly divided cells that exhibited the cut phenotype
(Fig. 4 A, right gallery, rows 2 and 3) along with a slight in-
crease in apoptotic cells. Normal telophase cells that were
Figure 2. Overexpression of a hBUBR1Dkinase pre-
vents cells from arresting in mitosis in the presence of
nocodazole. (A; rows 1 and 2) 12 h after release from
the G1/S boundary, cells expressing gfp:hBUBR1 (WT)
and the gfp:hBUBR1Dkinase mutant enter mitosis in
the presence of nocodazole. Both the gfp:hBUBR1
(WT) and the gfp:hBUBR1Dkinase mutant were con-
centrated at kinetochores (right). (row 3) After over-
night incubation in nocodazole, cells that expressed the
gfp:hBUBR1Dkinase mutant had exited mitosis and
formed aberrantly shaped nuclei (left). Gfp:fusion con-
structs were directly visualized by autofluorescence.
Chromosomes and nuclei were visualized with DAPI.
(B) Fates of Hela cells that expressed wild-type gfp:
hBUBR1 or gfp:hBUBR1Dkinase and exposed to no-
codazole. Synchronized Hela cells were transfected
z2 h after release from the G1/S boundary with wild-
type gfp:hBUBR1 or gfp:hBUBR1Dkinase; after 5 h,
the transfection mix was removed and nocodazole
was added. The mitotic (open bars), multinucleated
(striped bars), and apoptotic (dotted bars) indices of
wild-type gfp:hBUBR1 and gfp:hBUBR1Dkinase after
overnight incubation (z20 h after release from the G1/S
boundary) in nocodazole was compared. Approxi-
mately 120–150 transfected cells were counted and
scored for each experiment. The plotted values are the
means plus SD from at least three experiments. Bars,
10 mm. 
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coinjected with the hBUBR1 and CENP-E antibodies
were not found. These data showed that hBUBR1 is an es-
sential component of the mitotic checkpoint that is sen-
sitive to kinetochore functions that were specified by
CENP-E.
 
Characterization of hBUBR1 Protein Expression and 
Kinase Activity
 
Having established that hBUBR1 is an essential compo-
nent of the mitotic checkpoint, we wanted to investigate its
Figure 3. hBUBR1 is essential for cells to pro-
ceed normally through mitosis. (A) Synchronized
Hela cells released from the G1/S boundary were
injected with nonimmune or hBUBR1 antibodies
and sampled at 12 or 16 h later. (rows 1–3) 12 h
after release from the G1/S boundary, injected
cells entered mitosis. (row 1) Metaphase cell in-
jected with nonimmune IgG (middle) stained for
endogenous hBUBR1 (right). (rows 2 and 3)
Prometaphase and anaphase cells injected with
hBUBR1 antibodies (middle) and stained for
CENP-E (right). (row 4) 16 h after release from
the G1/S boundary, hBUBR1 injected cells (mid-
dle) divided with lagging chromosomes trapped
in the cleavage furrow. Centromeres (arrow-
heads) stained with ACA and visualized with
Texas red anti-human secondary antibodies. In-
sets in rows 3 and 4 are longer exposures and en-
largements of boxed areas. Injected antibodies
were visualized with Cy5 anti-rabbit secondary
antibody (middle). Endogenous hBUBR1 was
stained with rat anti–hBUBR1 and detected with
Cy2 anti-rat (row 1, right). CENP-E was stained
with mouse monoclonal anti-CENP-E (mAb177)
and detected with Cy2 anti-mouse secondary an-
tibodies (rows 2 and 3, right). Chromosomes and
nuclei were stained with DAPI (left). (B) 16 h af-
ter release from the G1/S boundary, nonimmune
IgG– and hBUBR1 antibody–injected cells were
scored for mitotic (open bar), normal telophase
(dotted bar) or aberrantly divided cut (checkered
bar) based on a combination of DAPI staining
and phase-contrast images. Histogram compares
relative percentages of each of the three pheno-
types. The plotted values are the means plus SD
from at least three experiments. (C) Cells ex-
pressing gfp:hBUBR1Dkinase exit mitosis with
prematurely. Synchronized Hela cells transfected
with gfp:hBUBR1Dkinase enter mitosis (top
row) 12 h after release from the G1/S boundary.
By 16 h, most cells expressing the kinase mutant
produced cells that divided with lagging chromo-
somes trapped in the cleavage furrow (bottom).
Bars, 10 mm. 
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mechanism of action by characterizing its expression and
kinase activity as a function of the cell cycle. hBUBR1 was
immunoprecipitated from K562 erythroleukemic cells and
Hela cells that were separated into different phases of the
cell cycles by centrifugal elutriation. Portions of the immu-
nocomplexes were used to determine steady-state levels of
protein and kinase activity. We assayed the immunopre-
cipitated hBUBR1 for autokinase activity as a recent
study showed that a transfected hBUBR1 exhibited au-
tokinase activity (Taylor et al., 1998). However, hBUBR1
isolated from K562 and Hela (data not shown) exhibited
no detectable autokinase activity (Fig. 5 A, top) or kinase
activities towards exogenous substrates (data not shown)
even though it was expressed throughout the cell cycle of
Figure 4. hBUBR1 is required for mitotic arrest resulting
from loss of CENP-E functions at kinetochores. Synchro-
nized Hela cells were injected with rabbit anti–CENP-E
and hBUBR1 antibodies and sampled at 12 or 16 h after
release from the G1/S boundary. (A) Immunofluorescence
staining of injected cells at these time points. (left gallery)
Cells injected with CENP-E antibodies arrest in mitosis
with unaligned chromosomes. Cells were stained for the in-
jected CENP-E antibodies (middle), localization of endog-
enous hBUBR1, ACA, and tubulin (rows 1–3, respectively,
right). (right gallery) Cells coinjected with CENP-E and
hBUBR1 antibodies (middle) enter mitosis with hBUBR1
at kinetochores (right, row 1). At the 16-h time points
(rows 2 and 3), the cells coinjected with CENP-E and
hBUBR1 antibodies exit mitosis with unaligned chromo-
somes to produce divided cells with lagging chromosomes
(inset in left) and multiple nuclei that reform around
unsegregated or incompletely separated chromosomes.
Phase-contrast image show cells were tethered at the stem-
body (row 2, right). Injected antibodies were stained with
Cy5 anti-rabbit secondary antibodies (middle columns of
both galleries). Endogenous hBUBR1 was stained with
anti-rat hBUBR1 and visualized with Cy2 anti-rat second-
ary antibody. ACA was visualized with Cy2 anti-human
secondary antibodies. Microtubules were detected with antitubulin mAbs and Cy2 anti-mouse secondary antibodies. Chromosomes and
nuclei were stained with DAPI (left column). (B) Comparison of the fates of cells injected with CENP-E antibodies, hBUBR11CENP-E
antibodies, and nonimmune IgG. After cells were released from the G1/S boundary for 16 h, the percentage of cells injected with the
various antibodies that were in mitosis (open bars), normal telophase (white dotted bar), cut (checkered bar), and apoptosis (black dot-
ted bar) were quantitated and compared. The plotted values are the means plus SDs from at least three experiments. Bars, 10 mm. 
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both cell types (Fig. 5 A, middle and bottom). hBUBR1
levels remained fairly constant throughout the cell cycle of
K562 cells, whereas hBUBR1 levels in Hela cells fluctu-
ated with the cell cycle. hBUBR1 level was lowest in G1
and steadily increased as cells progressed towards mitosis.
If hBUBR1 is a mitosis-specific kinase, its activity would
have escaped detection because the vast majority of the
cells that were elutriated into the late fractions were in G2
and only a very minor fraction was in mitosis. Therefore,
we compared the hBUBR1 kinase activity between in-
terphase and mitotically arrested Hela cells. hBUBR1
autokinase activity remained undetectable in interphase
cells, but was highly active in mitotically arrested cells
(Fig. 5 B). The same profile of hBUBR1 kinase activity
was obtained with exogenous substrates such as myelin ba-
sic protein and a carboxyl-terminal fragment of CENP-E
(data not shown). The increase in hBUBR1 kinase activity
in mitotic cells was not due to increased expression of the
protein or its association with the hBUB3 subunit relative
to interphase cells (Fig. 5 B, bottom). However, hBUBR1
mobility was reduced in mitotically blocked cells relative
to the interphase cells (Fig. 5 B, middle right). The upshift
was due to phosphorylation as the electrophoretic mobil-
ity of hBUBR1 was no longer retarded after phosphatase
treatment (Fig. 5 C, compare lanes 1 and 2). In vivo label-
ing experiments showed that hBUBR1 was also phos-
phorylated during interphase but became hyperphos-
phorylated in mitosis (data not shown). To further test if
the hyperphosphorylation of hBUBR1 was related to the
mitotic checkpoint, we compared hBUBR1 in mitotically
blocked cells to cells that were released from the block
and had exited mitosis (Fig. 5 C, right). The majority of
hBUBR1 was hyperphosphorylated in mitotically blocked
cells relative to normal mitotic cells. 1 h after their release
from the mitotic block, hBUBR1 was no longer hyper-
phosphorylated (Fig. 5 C, compare lanes 4 and 5).
In the previous experiments, hBUBR1 kinase activity
was determined in cells that had already been blocked in
mitosis for many hours. As a checkpoint kinase, hBUBR1
should respond to spindle defects even after cells have
reached metaphase. To test this, we isolated mitotic Hela
cells by mechanical shakeoff, and then exposed them to
nocodazole for various times. Microscopic analysis re-
vealed that 
 
.
 
90% of the mechanically detached cells were
in metaphase with some prometaphase and very few
(
 
,
 
1%) anaphase cells. hBUBR1 was immunoprecipitated
from cell lysates that were harvested at different times of
incubation with nocodazole, and then assayed for kinase
activities and protein expression (Fig. 6 A). Comparison of
hBUBR1 kinase activity between metaphase cells and
those that were exposed to nocodazole showed that kinase
activity was rapidly stimulated within 15 min of nocoda-
zole treatment (Fig. 6 A). At this time, the spindle was ab-
sent and chromosomes were unaligned (data not shown).
hBUBR1 kinase activity reached a peak at 30 min after
nocodazole treatment and gradually declined. By 4 h,
hBUBR1 kinase activity had decayed to a level that was
slightly above that of normal metaphase cells. During the
course of the experiment, cells were confirmed to be
blocked in mitosis by phase-contrast microscopy and ex-
pression levels of cyclin B (Fig. 6 B, bottom). Western
blots of the hBUBR1 immunoprecipitates revealed that
 
the levels of hBUBR1 and hBUB3 remained fairly con-
stant over the course of the experiment (Fig. 6 B). The in-
crease of kinase activity was not due to changes in levels of
hBUBR1 or its subunit, hBUB3. However, we detected an
increase in the level of hyperphosphorylated hBUBR1 (as
determined by retarded migration) between metaphase
cells and those that were incubated in nocodazole (Fig. 6
B, compare top bands of 0 min and 120 min). The increase
in the level of hyperphosphorylated hBUBR1 did not cor-
relate with its peak kinase activities (Fig. 6, A and B, com-
pare 30 min and 120 min time points).
The hBUBR1 kinase activities described above were
derived from the soluble pool of proteins and excluded
those that were associated with kinetochores. As the ki-
netochore is a critical component of the checkpoint, we
probed the insoluble fractions that were enriched in chro-
mosomes for hBUBR1 to see how this population re-
sponded to spindle disruption (Fig. 6 C). Western blots
revealed that hBUBR1 levels increased slightly after 30
and 60 min in nocodazole, but returned to the initial level
after 2 and 4 h of nocodazole treatment. The most dra-
matic change was that hBUBR1 was quantitatively hy-
perphosphorylated within 15 min of spindle disruption
and this high level of phosphorylation was maintained
throughout the block.
 
hBUBR1 Associates with the Cyclosome/APC
 
Next, we examined the native size of hBUBR1 between
interphase and mitotically blocked cells. Gel filtration
chromatography revealed that hBUBR1 exists primarily
in an 
 
z
 
500-kD complex in interphase cells (Fig. 7 A, top).
In mitotically arrested cells, hBUBR1 was associated with
the 
 
z
 
500-kD complex, but was also found in a larger com-
plex that overlapped with the cyclosome/APC (Fig. 7 A,
bottom). The possibility that hBUBR1 was associated with
the cyclosome/APC was tested by immunoprecipitating
hBUBR1 from the fractions containing the cyclosome/
APC and probing for the presence of the APC subunits
hscdc27, hscdc16 (Tugendreich et al., 1995), and APC7
(Yu et al., 1998). The results showed that all three of the
APC subunits, coimmunoprecipitated with hBUBR1 in
the mitotically blocked lysates (Fig. 7 B, middle). Al-
though some hBUBR1 was detected in the cyclosome/
APC containing fractions in interphase cells (Fig. 7 A,
top), this was not associated with the cyclosome/APC
(Fig. 7 B, left), and most likely resulted from smearing
of the 500-kD complex in the gel filtration column. This
finding along with the absence of cyclosome/APC sub-
units in immunoprecipitates from nonimmune IgG dem-
onstrated that the cyclosome/APC specifically associates
with hBUBR1 only in mitosis.
We estimated the proportion of the cellular pool of the
cyclosome/APC that was associated with hBUBR1 in mi-
totically arrested cells by comparing the relative levels of
various APC subunits in hBUBR1 immunoprecipitates
and the remaining supernatant. When 
 
z
 
30% of the total
pool of hBUBR1 was immunoprecipitated from mitotic
lysates, roughly 16–20% of the total pool of hscdc16,
hscdc27, and APC7 was also found in the precipitate. As-
suming that the remaining pool of hBUBR1 that was not
immunoprecipitated can also associate with the APC, we 
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can extrapolate that 
 
z
 
50% of the total pool of APC can
be associated with hBUBR1. Since the gel filtration data
show that 
 
z
 
50% of the total pool of hBUBR1 comigrates
with the APC, we estimate that about 25% of the total
pool of APC is associated with hBUBR1 in mitosis.
 
Discussion
 
hBUBR1 Is Essential for the Mitotic Checkpoint
 
The results from this study provide details about the func-
tion and biochemical properties of hBUBR1 kinase. We
demonstrate that hBUBR1 is essential for the mitotic
checkpoint as disruption of hBUBR1 function prevented
cells from arresting in mitosis in the presence of nocoda-
zole. Instead, the cells exited mitosis without dividing and
formed highly aberrant nuclei that contained unsegre-
gated chromosomes. The behavior of hBUBR1-defective
cells is very similar to that exhibited by cells with defective
MAD1, MAD2, or BUB1 functions. Depletion of MAD2
and MAD1 from 
 
Xenopus 
 
egg extracts resulted in the in-
 
ability to block mitosis in the presence of nocodazole
(Chen et al., 1996, 1998). Introduction of anti-MAD2 anti-
bodies into cells abrogated their ability to arrest in mitosis
in the presence of nocodazole (Li and Benezra, 1996) or
taxol (Waters et al., 1998). Overexpression of a mutant
form of mBUB1 (Taylor and McKeon, 1997) and hBUB1
(Cahill et al., 1998) prevented cells from arresting in mito-
sis in the presence of nocodazole.
Our studies also showed that hBUBR1 provided an es-
sential function during normal mitosis by preventing cells
from prematurely exiting mitosis. It was unlikely that
disrupting hBUBR1 functions directly interfered with
chromosome alignment since we were able to identify
metaphase cells that were injected with hBUBR1 antibody
or expressed the hBUBR1 kinase–defective mutant. As
the frequency of such metaphase cells was rare, the most
likely fate of many of the prometaphase cells that we saw
was premature exit from mitosis. This interpretation is
supported by the identification of aberrant anaphase cells
with lagging chromosomes. The lagging chromosomes
most likely were chromosomes that had not achieved
Figure 5. hBUBR1 expression, phosphorylation, and ki-
nase activity during the cell cycle. (A) K562 and Hela cells
were separated according to their position in the cell cycle
by centrifugal elutriation. hBUBR1 was immunoprecipi-
tated from equal amounts of protein from each fraction,
and then tested for autokinase activity (top) or probed
with hBUBR1 antibodies to compare its cell cycle expres-
sion profile (middle and bottom). (B) Comparison of au-
tokinase activity (top) and levels of hBUBR1 (middle) and
hBUB3 found in hBUBR1 immunoprecipitates from asyn-
chronous interphase cells (A) or cells blocked in mitosis by
nocodazole (N). (C) hBUBR1 is hyperphosphorylated in
mitosis. hBUBR1 immunoprecipitated from mitotically
blocked Hela cells were incubated in the presence (lane 1)
or absence (lane 2) of lambda protein phosphatase (lPP).
(lanes 3–8) Comparison of hyperphosphorylation status of
hBUBR1 in normal mitotic Hela cells (lane 3, M), nocoda-
zole-blocked mitotic cells (lane 4, N), or cells released from
the nocodazole block for 1, 2, 3, and 4 h (lanes 5–8, respec-
tively). Cells were determined to have reentered G1 by
phase-contrast microscopy. 
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alignment at the metaphase plate when cells decided to
exit mitosis. This defect would explain the high frequency
of abnormally divided cells that contained chromatin
trapped by the cleavage furrow. At present, we have not
directly determined precisely how rapidly cells progress
through mitosis when hBUBR1 function is inhibited.
However, studies have shown that disruption of mBUB1
appeared to accelerate cells through mitosis by 
 
z
 
25 min
(Taylor and McKeon, 1998). Likewise, microinjection of
MAD2 antibodies into prophase human keratinocyte cells
caused them to precociously exit mitosis before chro-
mosomes were properly aligned (Gorbsky et al., 1998).
High resolution videomicroscopy showed that disruption
of MAD2 in human keratinocyte cells accelerated mitotic
progression by 6.5 min. Despite the similarity in the out-
comes of all these studies, it remains to be seen how
MAD2, BUB1, and BUBR1 relate to each other at a
mechanistic level. As all of these proteins are localized at
the kinetochore, they may act in parallel by monitoring
different activities of the kinetochore or work as an inte-
grated complex to generate the wait anaphase signal from
the kinetochore. These two possibilities are supported by
the fact that the two BUB1-related kinases do not share
overlapping functions as neither one is able to maintain
the mitotic checkpoint alone.
 
hBUBR1 Is Sensitive to CENP-E Functions
at Kinetochores
 
Our data show that one checkpoint function of hBUBR1
is to monitor kinetochore functions that are specified by
CENP-E. When kinetochores are depleted of CENP-E,
cells arrest in mitosis with unaligned chromosomes but a
normal spindle. Our data suggest that hBUBR1 activity at
the kinetochore is important for generating the wait
anaphase signal. This possibility is supported by the find-
ing that hBUBR1 was still present on kinetochores that
lacked CENP-E. Furthermore, microinjection of hBUBR1
antibodies abrogated the mitotic arrest and caused cells to
exit mitosis. If hBUBR1 was contributing to the wait
anaphase signal from the CENP-E–depleted kinetochores,
it must be able to do so when it is not in direct contact with
CENP-E. Under normal circumstances, we speculate that
interactions between CENP-E and microtubules can di-
rectly regulate hBUBR1 activity by altering its interac-
tions with CENP-E.
Although such a feedback mechanism can link kineto-
chore attachments to the checkpoint, the threshold level of
CENP-E activity that is required to activate or inactivate
hBUBR1 activity remains to be determined. We have
shown that when kinetochore–microtubule attachments of
metaphase cells are dissolved by nocodazole, the most dra-
matic change was the quantitative hyperphosphorylation
of the kinetochore-bound hBUBR1. Perhaps the phos-
phorylation state of hBUBR1 at the kinetochore is related
to the number of kinetochore microtubules that are attached
to CENP-E and the level of tension that results from these
interactions. At metaphase, the levels of both CENP-E
and hBUBR1 have been shown to be reduced (Chan et al.,
1998; Jablonski et al., 1998) along with other checkpoint
proteins. Under these circumstances, there may be insuffi-
cient hBUBR1 kinase activity that is generated from the
kinetochore to sustain the checkpoint components that lie
downstream of the kinetochore. Studies have shown that it
takes 
 
z
 
30 min from the time the last chromosome be-
comes aligned at the metaphase plate until the onset of
anaphase (Rieder et al., 1995). This may be the time that is
required for the checkpoint signal to fall and to allow cy-
closome/APC activity to reach a critical level that is neces-
sary to drive cells into anaphase. Before this critical level
of cyclosome/APC activity is reached, the checkpoint
can be reactivated by unattached kinetochores to once
again inhibit cyclosome/APC. Although we proposed that
hBUBR1 kinase activity is sensitive to the mechanical ac-
Figure 6. hBUBR1 kinase in metaphase Hela cells are stimulated
by disruption of the spindle. Mitotic shakeoff cells that were
nearly uniformly at metaphase were exposed to nocodazole for
the times indicated and hBUBR1 complexes were immunopre-
cipitated from cell lysates and probed for autokinase activity. (A)
hBUBR1 autokinase activity from each time point was quanti-
tated with a PhosphorImager and normalized to metaphase cells
(time 0). This is a valid comparison as equal amounts of hBUBR1
were used for the kinase assay. (B) Western blots of hBUBR1
immunoprecipitates probed with hBUBR1 (top) and hBUB3
(middle). Lysates obtained from the same experiment were sepa-
rately probed for cyclin B expression (bottom). (C) Western blot
of the insoluble chromosome fractions obtained from the experi-
ment described above was probed for hBUBR1. 
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tivities of the kinetochore, activation of its kinase may re-
quire additional biochemical changes such as mitosis-spe-
cific phosphorylations. As kinetochores are now known to
also contain cdc2 (Rattner et al., 1990), MAP kinase (Sha-
piro et al., 1998; Zecevic et al., 1998), and hBUB1
(mBUB1) kinases (Taylor and McKeon, 1997; Jablonski et
al., 1998), any one of these may be important for regulat-
ing hBUBR1 kinase at the kinetochore.
 
hBUBR1 Is Associated with the Cyclosome/APC
in Mitosis
 
We infer from the interaction between hBUBR1 and cy-
closome/APC that hBUBR1 might provide global check-
point functions by directly inhibiting cyclosome/APC. This
is supported by the finding that partially purified hBUBR1
from Hela cells inhibited ubiquitination activity of the
APC in vitro (Sudakin, V., and T. Yen, unpublished re-
sults). By comparing the amount of APC that coimmuno-
precipitated with hBUBR1 to that in the remaining super-
natant, we estimated that 25% of the total pool of APC
was bound to hBUBR1. As MAD2–p55cdc was also found
to be associated with only a fraction of the total pool of
APC, it is possible that the hBUBR1–APC complex
represents a different subpopulation of the APC. As
hBUBR1 kinase activity is stimulated when the spindle is
disrupted, hBUBR1 may directly phosphorylate and in-
hibit cyclosome/APC activity or phosphorylate specific
substrates so that they are no longer recognized by the cy-
closome/APC.
As proposed for MAD2–p55cdc (Gorbsky et al., 1998),
the interactions between hBUBR1 and the cyclosome/
APC should be inherently unstable so that cells can pro-
ceed into anaphase when the checkpoint is extinguished.
As hBUBR1 appears to form a fairly stable complex with
the cyclosome/APC in cells arrested in mitosis, its kinase
activity may be labile. This is supported by the observation
that the in vitro hBUBR1 kinase activity had decayed
when it was isolated from cells whose spindle had been
disrupted by nocodazole for an hour as compared with the
mitotic cells that were examined 30 min earlier. As the
phosphorylation status of the soluble pool of hBUBR1 did
Figure 7. hBUBR1 associates with the
cyclosome/APC during mitosis. (A) Ly-
sates prepared from Hela cells enriched
in G1 by centrifugal elutriation (inter-
phase) or blocked in mitosis with no-
codazole were separated on a Superose
6 column by FPLC. Individual fractions
were probed with hBUBR1 antibodies
(top) and hscdc16 antibodies (bottom).
Fractions 21–25 contain the cyclosome/
APC as determined by size markers
and presence of cyclosome/APC sub-
units, hscdc16 (bottom), hscdc27, and
APC7 (not shown). The column was
calibrated with three different size
markers as indicated by the arrows. (B)
Fractions 21–25 from the interphase
and mitotic gel filtration columns that
contained peak levels of cyclosome/
APC were pooled and immunoprecipi-
tated with hBUBR1 antibodies (left
and middle columns) or nonimmune
antibodies (right column, mitotic sam-
ples only). Immunoprecipitates were
probed with antibodies to hBUBR1
and three different cyclosome/APC
subunits. (C) hBUBR1 immunoprecipi-
tates from nocodazole-blocked mitotic
Hela lysates were probed for hBUBR1,
and the cyclosome/APC subunits
hscdc27, hscdc16, and APC7. 20% of
the remaining supernatant (after re-
moval of the IP) was also probed for
the presence of these proteins by West-
ern blots. Samples were probed at the
same time and exposed to film for iden-
tical times. Exposures were chosen that
had not saturated the film. Relative
band intensities were estimated. For example, the Western blots indicated that there was approximately twice the amount of hBUBR1
in the IP than in the supernatant. Taking into consideration that the hBUBR1 signal in the supernatant represented only one fifth of the
input, the ratio of hBUBR1 between IP and supernatant was z2:5. From this ratio, we calculated that 28% of the total pool of hBUBR1
was found in the IP. The broad cdc27 bands in the mitotic samples has been shown to be hyperphosphorylation (Yu et al., 1998). 
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not strongly correlate with its kinase activity, additional
factors may influence hBUBR1 kinase activity. Despite
the decay in the soluble pool of hBUBR1 kinase activity,
sufficient kinase activity was probably maintained in the
mitotically arrested cells by the continued presence of un-
attached kinetochores.
 
Proposed Mechanism of Action of hBUBR1
 
The cumulative results obtained for hBUBR1 suggest that
it can provide checkpoint functions at the local and global
levels. In the simplest model, unattached kinetochores
contain active hBUBR1 kinase that can rapidly activate
the soluble pool of hBUBR1 through autophosphoryla-
tion. This then leads to inhibition of the cyclosome/APC
and exit from mitosis. This model of hBUBR1 function
shares features proposed for MAD2–p55cdc and MAD2/
MAD1 (Chen et al., 1998; Gorbsky et al., 1998; Kallio et al.,
1998). The overall view is that a soluble pool of checkpoint
proteins is used to block cyclosome/APC activity, but the
inhibitory status of these checkpoint proteins must be
maintained through interactions with the unattached ki-
netochore. We propose that hBUBR1 can accomplish this
through an autokinase loop that may also include MAD2–
p55cdc complex. As MAD2 is not known to be hyper-
phosphorylated in mitotically blocked cells, hBUBR1
might phosphorylate one of its associated subunits such as
p55CDC (Weinstein, 1997) or MAD1 (Chen et al., 1998;
Jin et al., 1998). Biochemical analysis of yeast MAD1
showed that it is hyperphosphorylated in mitotically ar-
rested cells and that this is dependent on the MPS1 and
BUB1 kinases (Hardwick and Murray, 1995). Although
vertebrate MAD1 does not undergo phosphorylation-
dependent shifts in its migration in SDS-PAGE (Chen et
al., 1998; Jin et al., 1998), it does not eliminate the possibil-
ity that MAD1 is hyperphosphorylated in mitosis. It is pos-
sible that in vertebrate systems, MAD1, MAD2, p55CDC,
and hBUB1 act in parallel with hBUBR1 or through more
complex interactions. Clearly, it will be important to clar-
ify the biochemical relationship amongst these proteins to
resolve whether they act together or along separate path-
ways in vertebrate cells.
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